Amedisys (FRA:ADY) COGS-to-Revenue : 0.56 (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Amedisys COGS-to-Revenue?

Amedisys's Cost of Goods Sold for the three months ended in Mar. 2024 was €296 Mil. Its Revenue for the three months ended in Mar. 2024 was €526 Mil.

Amedisys's COGS to Revenue for the three months ended in Mar. 2024 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Amedisys's Gross Margin % for the three months ended in Mar. 2024 was 43.73%.

Amedisys COGS-to-Revenue Historical Data

The historical data trend for Amedisys's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amedisys COGS-to-Revenue Chart

Amedisys Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.59

0.57

0.56

0.57

0.56

Amedisys Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.57	0.54	0.56	0.56	0.56

Amedisys COGS-to-Revenue Calculation

Amedisys's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1142.131	/	2050.762
	=	0.56

Amedisys's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	295.814	/	525.701
	=	0.56

Amedisys (FRA:ADY) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Amedisys's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	295.814 / 525.701
	=	43.73 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Amedisys COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Amedisys's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Amedisys (FRA:ADY) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Amedisys Inc (FRA:ADY) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

AMED:USA ADY:Germany

Address

3854 American Way, Suite A, Baton Rouge, LA, USA, 70816

Website

https://www.amedisys.com

Amedisys Inc is a healthcare services company in the United States. The company brings healthcare to the home through the provision of home healthcare services, hospice services, high acuity care segment, and personal care services. The Home Health Segment provides skilled nurses, therapists, and aids to patients' homes throughout the United States, Hospice segment operates many centers designed to provide comfort and support for terminally ill patients, Personal Care Segment provides individuals with assistance in their daily living activities and High acuity care segment can deliver the essential elements of inpatient hospital, SNF care, and palliative care to patients in their homes. A majority of the company's revenue is derived from the Home Health segment.

Amedisys (FRA:ADY) Headlines

No Headlines